At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Hypoglycemia Reduction in Type 1 Diabetes
In Brief
A clinical study evaluating AP System (DiAs or inControl) with USS Virginia and Sensor-Augmented Pump Therapy (placebo) for Type 1 Diabetes Mellitus. Completed, enrolled 85 participants across 2 sites.
Detailed Summary
This is a randomized, controlled trial of Unified Safety System (USS) Virginia closed-loop versus sensor-augmented pump (SAP) therapy for hypoglycemia prevention in subjects with type 1 diabetes and hypoglycemia unawareness and/or risk for hypoglycemia.
Study Details
Timeline
Interventions
Subject will participate in two 24-hour study insulin pump and AP System training sessions. At the conclusion of each training session, subject will wear the equipment at home for a total of 5 weeks.
Subject will participate in 5 weeks use of CGM and personal insulin pump at home.